	Despesas De Vendas E Administração		Data
Acadia Pharmaceuticals	USD 124.9M	1.24M	2025-09
Alnylam Pharmaceuticals	USD 285.06M	22.47M	2025-12
Amgen	USD 1.94B	237M	2025-12
BioCryst Pharmaceuticals	USD 80.47M	15.39M	2024-12
Biogen	USD 545.2M	38.6M	2025-09
BioMarin Pharmaceutical	USD 223.42M	8.86M	2025-09
Cytokinetics	USD 158.75M	93.03M	2025-09
Daiichi Sankyo	JPY 228.23B	39.15B	2025-12
Enanta Pharmaceuticals	USD -1.05	0.31	2024-12
Esperion Therapeutics	USD 39.98M	4.21M	2024-09
Gilead Sciences	USD 1.78B	425M	2025-12
Incyte	USD 390.41M	61.33M	2025-12
Ionis Pharmaceuticals	USD 86.56M	4.04M	2025-09
Ironwood Pharmaceuticals	USD 33.33M	2.78M	2024-12
Karyopharm Therapeutics	USD 27.19M	442K	2024-12
Novartis	USD 3.31B	134M	2025-09
Pfizer	USD 4.08B	894M	2025-12
PTC Therapeutics	USD 87.2M	3.15M	2025-12
Puma Biotechnology	USD 16.82M	8.15M	2024-09
Roche Holding	CHF 7.28B	3.99B	2025-12
Sangamo BioSciences	USD 9.64M	1.83M	2024-06
Sarepta Therapeutics	USD 77.11M	7.22M	2025-09
TG Therapeutics	USD 63.37M	51.33M	2025-09
Ultragenyx Pharmaceutical	USD 89M	2.38M	2025-12
Vertex Pharmaceuticals	USD 487M	41.9M	2025-12
Xencor	USD 87.78M	72.66M	2025-09

PTC Therapeutics Despesas De Vendas E Administração - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.